Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.

Autor: KAI-CHANG ZHU1,2, JIAN-MEI SUN3, JIAN-GUO SHEN2, JI-ZHONG JIN2, FENG LIU2, XIAO-LIN XU2, LIN CHEN2, LIN-TAO LIU2, JIA-JU LV1 lvjiaju@hotmail.com
Zdroj: Oncology Letters. Oct2015, Vol. 10 Issue 4, p2359-2365. 7p.
Databáze: Academic Search Ultimate